Dominant intermediate Charcot-Marie-Tooth neuropathy maps to chromosome 19p12-p13.2.

The hereditary disorders of peripheral nerve form one of the most common groups of human genetic diseases, collectively called Charcot-Marie-Tooth (CMT) neuropathy. Using linkage analysis we have identified a new locus for a form of CMT that we have called "dominant intermediate CMT" (DI-CMT). A genomewide screen using 383 microsatellite markers showed strong linkage to the short arm of chromosome 19 (maximum LOD score 4.3, with a recombination fraction (straight theta) of 0, at D19S221 and maximum LOD score 5.28, straight theta=0, at D19S226). Haplotype analysis performed with 14 additional markers placed the DI-CMT locus within a 16.8-cM region flanked by the markers D19S586 and D19S546. Multipoint linkage analysis suggested the most likely location at D19S226 (maximum multipoint LOD score 6.77), within a 10-cM confidence interval. This study establishes the presence of a locus for DI-CMT on chromosome 19p12-p13.2.

[1]  N. Hirokawa,et al.  Charcot-Marie-Tooth Disease Type 2A Caused by Mutation in a Microtubule Motor KIF1Bβ , 2001, Cell.

[2]  N. Wood,et al.  A novel TRK A (NTRK1) mutation associated with hereditary sensory and autonomic neuropathy type V , 2001, Annals of neurology.

[3]  A. Mégarbané,et al.  A mutation in periaxin is responsible for CMT4F, an autosomal recessive form of Charcot-Marie-Tooth disease. , 2001, Human molecular genetics.

[4]  C. Falk,et al.  Identification of a locus for autosomal dominant polycystic liver disease, on chromosome 19p13.2-13.1. , 2000, American journal of human genetics.

[5]  J. Meuleman,et al.  Molecular genetics of inherited peripheral neuropathies: who are the actors? , 2000, Acta neurologica Belgica.

[6]  O. Evgrafov,et al.  A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. , 2000, American journal of human genetics.

[7]  P K Thomas,et al.  N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom. , 2000, American journal of human genetics.

[8]  Aldo Quattrone,et al.  Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2 , 2000, Nature Genetics.

[9]  V. Timmerman,et al.  Charcot‐Marie‐Tooth Neuropathy Type 2 and P0 Point Mutations: Two Novel Amino Acid Substitutions (Asp61Gly; Tyr119Cys) and a Possible “Hotspot” on Thr124Met , 2000, Brain pathology.

[10]  J. Bonnefoy,et al.  BSMAP, a novel protein expressed specifically in the brain whose gene is localized on chromosome 19p12. , 1999, Biochemical and biophysical research communications.

[11]  F. Mastaglia,et al.  Novel mutation in the myelin protein zero gene in a family with intermediate hereditary motor and sensory neuropathy , 1999, Journal of neurology, neurosurgery, and psychiatry.

[12]  C. van Broeckhoven,et al.  The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype. , 1999, Brain : a journal of neurology.

[13]  C. Broeckhoven,et al.  Charcot-Marie-Tooth disease: an intermediate form , 1998, Neuromuscular Disorders.

[14]  F. Muntoni,et al.  Charcot-Marie-Tooth disease type 2 associated with mutation of the myelin protein zero gene , 1998, Neurology.

[15]  J. Lupski,et al.  Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies , 1998, Nature Genetics.

[16]  R. Ophoff,et al.  Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene on chromosome 19p. , 1997, Human molecular genetics.

[17]  J. Weissenbach,et al.  Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia , 1996, Nature.

[18]  A. Cherryson,et al.  The gene for hereditary sensory neuropathy type I (HSN–I) maps to chromosome 9q22.1–q22.3 , 1996, Nature Genetics.

[19]  K. Fischbeck,et al.  Connexin mutations in X-linked Charcot-Marie-Tooth disease. , 1993, Science.

[20]  J. Nash,et al.  Intermediate nerve conduction velocities define X‐linked Charcot‐Marie‐Tooth neuropathy families , 1993, Neurology.

[21]  N. Shimizu,et al.  Structure and chromosomal localization of the gene encoding the human myelin protein zero (MPZ). , 1993, Genomics.

[22]  A A Schäffer,et al.  Faster sequential genetic linkage computations. , 1993, American journal of human genetics.

[23]  F. Baas,et al.  Identical point mutations of PMP–22 in Trembler–J mouse and Charcot–Marie–Tooth disease type 1A , 1992, Nature Genetics.

[24]  P. De Jonghe,et al.  The peripheral myelin protein gene PMP–22 is contained within the Charcot–Marie–Tooth disease type 1A duplication , 1992, Nature Genetics.

[25]  B. Trask,et al.  The gene for the peripheral myelin protein PMP–22 is a candidate for Charcot–Marie–Tooth disease type 1A , 1992, Nature Genetics.

[26]  D. Housman,et al.  The peripheral myelin gene PMP–22/GAS–3 is duplicated in Charcot–Marie–Tooth disease type 1A , 1992, Nature Genetics.

[27]  T. Bird,et al.  Peripheral myelin protein–22 gene maps in the duplication in chromosome 17p11.2 associated with Charcot–Marie–Tooth 1A , 1992, Nature Genetics.

[28]  F. Baas,et al.  Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a) , 1991, Neuromuscular Disorders.

[29]  Aravinda Chakravarti,et al.  DNA duplication associated with Charcot-Marie-Tooth disease type 1A , 1991, Cell.

[30]  Se-Jin Lee,et al.  Expression of growth/differentiation factor 1 in the nervous system: conservation of a bicistronic structure. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[31]  G. Nicholson,et al.  Penetrance of the hereditary motor and sensory neuropathy la mutation , 1991, Neurology.

[32]  N E Morton,et al.  Report of the Committee on Methods of Linkage Analysis and Reporting. , 1985, Cytogenetics and cell genetics.

[33]  J. Ott,et al.  Strategies for multilocus linkage analysis in humans. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[34]  P K Thomas,et al.  The clinical features of hereditary motor and sensory neuropathy types I and II. , 1980, Brain : a journal of neurology.

[35]  W. Bradley,et al.  The peroneal muscular atrophy syndrome: clinical, genetic, electrophysiological and nerve biopsy studies. I. Clinical, genetic and electrophysiological findings and classification. , 1978, Journal de genetique humaine.

[36]  P. Salisachs.  Wide spectrum of motor conduction velocity in Charcot-Marie-Tooth disease. An anatomico-physiological interpretation. , 1974, Journal of the neurological sciences.

[37]  P. Dyck,et al.  Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. II. Neurologic, genetic, and electrophysiologic findings in various neuronal degenerations. , 1968, Archives of neurology.

[38]  G. Schmitz,et al.  Two novel mutant alleles of the gene encoding neurotrophic tyrosine kinase receptor type 1 (NTRK1) in a patient with congenital insensitivity to pain with anhidrosis: A splice junction mutation in intron 5 and cluster of four mutations in exon 15 , 2001, Human mutation.

[39]  M. Ferrari,et al.  A 3-Mb Region for the Familial Hemiplegic Migraine Locus on 19p13.1–p13.2: Exclusion of PRKCSH as a Candidate Gene , 1996, European journal of human genetics : EJHG.